Sector Update: Healthcare

09:00 AM EDT, 09/14/2026 (MT Newswires) -- Healthcare stocks were rising premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) advancing by 1.1% and the iShares Biotechnology ETF (IBB) 0.3% higher. GSK (GSK) licensor Hansoh Pharmaceutical reported that a phase 3 trial evaluating risvutatug rezetecan, or Ris-Rez, against commonly used topotecan in patients with relapsed small-cell lung cancer met its primary endpoint. GSK stock was up more than 4% pre-bell.